# Stifel Starts Establishment Labs Coverage With Buy Rating, $84 Target

By Enna Lee

Canonical URL: https://www.tokenpost.com/news/investing/32894
Published: 2026-10-16T00:22:41.000Z
Updated: 2026-10-16T00:22:41.000Z
Section: Investing

> The firm pointed to growth potential in the breast augmentation market. Establishment Labs shares gained in Thursday trading.

Establishment Labs Holdings Inc. (NASDAQ: ESTA) gained in Thursday trading as Stifel opened analyst coverage of the breast implant maker, assigning its shares a Buy rating and an $84 price target.

Stifel’s rationale was its assessment of the breast augmentation market’s growth outlook.